Citigroup’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43M Buy
5,117
+808
+19% +$233K ﹤0.01% 2881
2025
Q4
$1.31M Buy
4,309
+459
+12% +$143K ﹤0.01% 2959
2025
Q3
$1.08M Sell
3,850
-57,831
-94% -$15.7M ﹤0.01% 3117
2025
Q2
$14.9M Buy
61,681
+27,052
+78% +$6.39M 0.01% 1135
2025
Q1
$8.43M Buy
34,629
+13,635
+65% +$4.1M 0.01% 1478
2024
Q4
$6.9M Sell
20,994
-1,507
-7% -$512K 0.01% 1659
2024
Q3
$7.53M Sell
22,501
-4,014
-15% -$1.27M 0.01% 1517
2024
Q2
$7.24M Buy
26,515
+14,646
+123% +$4.26M 0.01% 1418
2024
Q1
$4.11M Buy
11,869
+240
+2% +$78.9K ﹤0.01% 1862
2023
Q4
$3.75M Sell
11,629
-1,508
-11% -$473K 0.01% 1789
2023
Q3
$4.71M Sell
13,137
-1,799
-12% -$694K 0.01% 1466
2023
Q2
$5.66M Sell
14,936
-4,009
-21% -$1.63M 0.01% 1422
2023
Q1
$9.08M Buy
18,945
+3,091
+19% +$1.45M 0.01% 1210
2022
Q4
$6.67M Sell
15,854
-2,287
-13% -$923K 0.01% 1332
2022
Q3
$7.57M Buy
18,141
+3,851
+27% +$1.92M 0.01% 1296
2022
Q2
$7.07M Sell
14,290
-3,070
-18% -$1.6M 0.01% 1330
2022
Q1
$9.78M Buy
17,360
+1,259
+8% +$759K 0.01% 1312
2021
Q4
$12.2M Sell
16,101
-1,796
-10% -$1.34M 0.01% 1285
2021
Q3
$13.3M Sell
17,897
-3,513
-16% -$2.63M 0.01% 1240
2021
Q2
$13.8M Sell
21,410
-2,972
-12% -$1.81M 0.01% 1220
2021
Q1
$13.9M Buy
24,382
+3,998
+20% +$2.37M 0.01% 1164
2020
Q4
$11.9M Buy
20,384
+501
+3% +$285K 0.01% 1412
2020
Q3
$10.3M Sell
19,883
-6,928
-26% -$3.51M 0.01% 1361
2020
Q2
$12.1M Buy
26,811
+16,311
+155% +$7.2M 0.02% 1166
2020
Q1
$3.68M Sell
10,500
-1,445
-12% -$531K 0.01% 1926
2019
Q4
$4.42M Buy
11,945
+3,446
+41% +$1.21M 0.01% 2135
2019
Q3
$2.83M Sell
8,499
-5,579
-40% -$1.82M ﹤0.01% 2492
2019
Q2
$4.4M Sell
14,078
-368
-3% -$110K 0.01% 2069
2019
Q1
$4.42M Buy
14,446
+8,478
+142% +$2.29M 0.01% 1906
2018
Q4
$1.39M Sell
5,968
-3,395
-36% -$911K ﹤0.01% 3047
2018
Q3
$2.93M Buy
9,363
+3,091
+49% +$959K 0.01% 2365
2018
Q2
$1.81M Sell
6,272
-1,390
-18% -$384K ﹤0.01% 2761
2018
Q1
$1.92M Sell
7,662
-35,423
-82% -$9.02M ﹤0.01% 2633
2017
Q4
$10.3M Buy
43,085
+21,518
+100% +$5.21M 0.02% 1275
2017
Q3
$4.79M Buy
21,567
+16,241
+305% +$3.65M 0.01% 1808
2017
Q2
$1.21M Buy
5,326
+2,049
+63% +$446K ﹤0.01% 3118
2017
Q1
$653K Sell
3,277
-10,502
-76% -$2.02M ﹤0.01% 3642
2016
Q4
$2.51M Sell
13,779
-5,764
-29% -$983K 0.01% 2669
2016
Q3
$3.2M Sell
19,543
-17,191
-47% -$2.61M 0.01% 2074
2016
Q2
$5.25M Sell
36,734
-622
-2% -$88.7K 0.01% 1539
2016
Q1
$5.11M Buy
37,356
+6,177
+20% +$811K 0.01% 1534
2015
Q4
$4.32M Buy
31,179
+23,172
+289% +$3.21M 0.01% 1820
2015
Q3
$1.08M Buy
8,007
+1,524
+24% +$219K ﹤0.01% 3009
2015
Q2
$976K Sell
6,483
-549
-8% -$78.5K ﹤0.01% 3168
2015
Q1
$952K Buy
7,032
+1,517
+28% +$188K ﹤0.01% 3123
2014
Q4
$665K Buy
5,515
+1,724
+45% +$198K ﹤0.01% 3580
2014
Q3
$430K Sell
3,791
-649
-15% -$76.9K ﹤0.01% 3653
2014
Q2
$532K Buy
4,440
+914
+26% +$112K ﹤0.01% 3427
2014
Q1
$452K Buy
3,526
+35
+1% +$4.49K ﹤0.01% 3570
2013
Q4
$432K Sell
3,491
-166
-5% -$20.2K ﹤0.01% 3936
2013
Q3
$430K Sell
3,657
-1,333
-27% -$157K ﹤0.01% 3549
2013
Q2
$561K Buy
+4,990
New +$585K ﹤0.01% 3382

Other funds holding BIO